Loading...
Loading...
India's pantoprazole imports from AUSTRALIA total $304 across 3 shipments from 1 foreign suppliers. ARROTEX PHARMACEUTICAL PTY LTD leads with $304 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include APOTEX RESEARCH PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for pantoprazole — a concentrated sourcing relationship with select suppliers from AUSTRALIA.

ARROTEX PHARMACEUTICAL PTY LTD is the leading Pantoprazole supplier from AUSTRALIA to India, with import value of $304 across 3 shipments. The top 5 suppliers — ARROTEX PHARMACEUTICAL PTY LTD — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ARROTEX PHARMACEUTICAL PTY LTD | $304 | 3 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | APOTEX RESEARCH PRIVATE LIMITED | $304 | 3 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Pantoprazole suppliers from AUSTRALIA to India include ARROTEX PHARMACEUTICAL PTY LTD. The leading supplier is ARROTEX PHARMACEUTICAL PTY LTD with import value of $304 USD across 3 shipments. India imported Pantoprazole worth $304 USD from AUSTRALIA in total across 3 shipments.
India imported Pantoprazole worth $304 USD from AUSTRALIA across 3 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Pantoprazole sourced from AUSTRALIA include APOTEX RESEARCH PRIVATE LIMITED. The largest buyer is APOTEX RESEARCH PRIVATE LIMITED with $304 in imports across 3 shipments.
The total value of Pantoprazole imports from AUSTRALIA to India is $304 USD, across 3 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists